Obesity represents a major modifiable risk factor for OSA, with a substantial proportion of OSA patients being overweight or obese
Missing a single dose by 1 to 2 days is unlikely to significantly disrupt your weight loss progress, though some patients report mild appetite rebound within 3 to 4 days
In a preliminary observational study of 387 adults using GLP-1 or dual GIP/GLP-1 medications, participants reported an average protein intake of just 33.4 grams per day
[1] Other risk factors include major trauma, scoliosis, and certain types of surgery
Some sources cite a true monthly semaglutide price closer to $239, and pricing varies by plan, so treat the first-month figure as a promo that rises afterward
Supplementary Material Contributor Information Cormac Kennedy, Department of Pharmacology and Therapeutics, School of Medicine, Trinity College Dublin, Dublin D02 PN40, Ireland